查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197384

腹腔镜设备市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Laparoscopy Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，腹腔镜设备市场预计将以 7.9% 的复合年增长率增长。

在 COVID-19 大流行期间，世界各地的医院都实行了社交距离措施，并减少了择期和非紧急病例，以避免传播病毒。 然而，紧急妇科和癌症手术正在进行中，确保所有剧院工作人员的安全和 SARS-CoV-2 病毒在对无症状或确诊的 COVID-19 患者进行手术时。将感染风险降至最低非常重要 例如，2020 年 3 月，沙特国家癌症研究所 (SANCI) 发布了护理人员和癌症设施指南，以减少 COVID-19 对癌症患者的影响。 COVID-19 大流行对该地区的泌尿外科实践和泌尿科医生招聘产生了重大影响。 由于大流行期间对医疗保健系统的特殊影响，泌尿外科实践正在发生变化。 2020 年发表在 Dove Press 上的一项研究发现，在大流行期间，泌尿科护理的延误有所增加，导致门诊等待八週。 然而，随着 COVID 病例开始下降，手术开始恢復到 COVID 之前的水平。

推动市场增长的因素包括技术进步、慢性病流行以及对微创手术的需求增加。 微创手术 (MIS) 引起的术后疼痛较少，因此患者需要的止痛药较少。 另外，由于切口和缝线很少，住院时间也比较短，不需要经常去医院就诊。

传统的剖腹手术需要在肌肉上做一个长切口，这需要很长时间才能恢復。 由于恢復时间相对较短，这种手术在老年人中被广泛接受。 美国妇科腹腔镜医师协会 (AAGL) 和国际妇科内镜医师协会 (ISGE) 等多个组织正在与南非医疗机构合作，以提高人们对 MIS 益处的认识并提高采用率。我们正在努力改进.

慢性病的增加增加了对更好治疗方案的需求。 因此，慢性病患者的数量预计将推动手术数量的增加，从而有助于一次性腹腔镜设备的增长。 例如，根据世界卫生组织公布的数据（2021年），全球死亡人数分别为心血管疾病（1790万）、癌症（930万）、呼吸系统疾病（410万）和糖尿病（410万）1.5百万）。

因此，与微创手术相关的好处正在推高采用率，这可能会在预测期内进一步推动整个市场的增长。

腹腔镜设备市场趋势

减肥手术有望在应用领域占有重要的市场份额

减肥手术或减肥手术是治疗肥胖症的主要治疗方法之一。 在这种手术中，胃的一部分被切除或使用胃束带来缩小胃的大小。 世界范围内儿童和青少年的肥胖率不断上升，导致一些年轻患者接受了减肥手术。

越来越多的减肥手术可能会增加对一次性腹腔镜设备的需求。 例如，根据 Ergie P.Inocian 等人于 2021 年 6 月发表在《肥胖及相关疾病外科杂誌》上的一项研究，中东为解决肥胖和代谢紊乱问题而进行的减肥手术数量正在增加。 因此，减肥手术继续被中东和北非地区接受为治疗严重肥胖症的方法，预计将对市场增长产生积极影响。

根据世界卫生组织 (WHO) 的数据，到 2021 年，全球肥胖人数将是 1975 年的近两倍。 同期，5-19 岁年龄组的肥胖率从 <1% 增加到 7%。 世界卫生组织说，世界上大多数人生活在超重或肥胖致死人数多于体重不足致死的国家。 减肥手术通过限制胃能容纳的食物量来减轻体重，导致营养吸收不良，或胃限制和吸收不良的结合。 与减肥手术一样，腹腔镜减肥手术对老年人来说是安全的。

北美主导市场，预计在预测期内将继续占据主导地位

北美预计将主导全球腹腔镜设备市场。 该地区的高速增长是由肥胖病例增加、各种慢性病和越来越多地采用微创手术推动的。

根据美国疾病控制与预防中心于 2021 年 4 月更新的一篇文章，十分之六的美国成年人至少患有一种慢性病，十分之四的成年人患有两种慢性病。我患有不止一种慢性病. 因此，国内慢性病的高患病率增加了对微创手术的需求，带动了腹腔镜器械市场。

此外，还采用了有机和无机战略，例如併购以及与主要市场参与者的合作伙伴关係，以加强公司的产品组合併推动市场研究。 此外，市场上推出的几种产品有望带来良好的市场增长。 例如，2021 年 6 月，强生医疗器械公司旗下的 Ethicon 宣布推出一种新型先进的双极能量设备，该设备可提高手术效率，提供更牢固的密封并接触更多组织。推出 ENSEAL X1 Curved Jaw Tissue Sealer。 该设备适用于结直肠、妇科、减肥和胸外科手术。

微创手术具有创伤小、患者康復时间快、治疗费用低等优点，增加了该地区对腹腔镜设备的需求。 此外，美国现有企业在各种手术设备方面的进步可能会推动北美市场的增长。

腹腔镜器械市场竞争者分析

全球腹腔镜设备市场竞争激烈，由许多大型企业组成。 B. Braun Melsungen AG、Boston Scientific Corporation、ConMed Corporation、Johnson & Johnson (Ethicon Inc.)、Karl Storz GmbH &Co.KG、Medtronic PLC (Covidien)、Olympus Corporation、Richard Wolf GmbH、Smith &Nephew PLC、Stryker 等公司公司在腹腔镜设备市场占有很大份额。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 技术进步的增加
    • 慢性病患病率
    • 对微创手术的需求不断增长
  • 市场製约因素
    • 缺乏腹腔镜手术专业知识
    • 与这些设备相关的高成本
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（市场规模，按价值计算：百万美元）

  • 产品名称
    • 能源设备
    • 腹腔镜
    • 吸引器
    • 手持设备
    • 抽吸和供水设备
    • 其他产品
  • 申请
    • 减肥手术
    • 妇科手术
    • 结肠手术
    • 其他用途
  • 最终用户
    • 门诊中心
    • 医院和诊所
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • B. Braun Melsungen AG
    • Boston Scientific Corporation
    • ConMed Corporation
    • Johnson & Johnson（Ethicon Inc.）
    • Karl Storz GmbH & Co. KG
    • Medtronic PLC（Covidien）
    • Olympus Corporation
    • Richard Wolf GmbH
    • Smith & Nephew PLC
    • Stryker Corporation

第7章 市场机会今后动向

简介目录
Product Code: 66773

The laparoscopy devices market is expected to witness a CAGR of 7.9% during the forecast period.

During the COVID-19 pandemic, hospitals worldwide reduced elective and non-urgent cases to maintain social distancing and avoid transmission of the virus. However, urgent gynecological and cancer procedures were being performed, and it's critical that all theater staff be safeguarded, and the risk of SARS-CoV-2 viral transmission is minimized when operating on asymptomatic or diagnosed COVID-19 patients. For instance, the Saudi Arabia National Cancer Institute (SANCI) issued a guideline for caregivers and cancer facilities in March 2020 to reduce the impact of COVID-19 on cancer patients.​ The COVID-19 pandemic has significantly impacted urological care and urologist recruitment in this region. The urology practice has been changed due to the exceptional impact on the healthcare system during the pandemic. According to a 2020 study published in the Dove Press, an increase in delayed urological services during the pandemic resulted in a wait of 8 weeks in outpatient clinics.​ However, as COVID cases started declining, the number of surgeries performed began returning to the pre-COVID levels.

Certain factors driving the market growth include increasing technological advancements, the growing prevalence of chronic diseases, and the growing demand for minimally-invasive surgery. Minimally-invasive surgeries (MIS) cause less post-operative pain, and hence, patients receive smaller dosages of pain killers. There are minimal cuts or stitches involved, the hospital stay is relatively shorter, and patients need not visit the hospital frequently.

Traditional open surgeries involve long incisions made through the muscles, and these muscles take a considerable amount of time to heal, whereas MIS procedures involve smaller incisions, leading to a quicker recovery. These surgeries have been gaining wider acceptance among the geriatric population due to the relatively shorter recovery time. Few organizations, such as the American Association of Gynecologic Laparoscopists (AAGL) and the International Society of Gynecologic Endoscopy (ISGE), have been collaborating with healthcare agencies in South Africa to create awareness about the benefits of MIS and improve the adoption rate.

The rising prevalence of chronic diseases is driving up the demand for better treatment measures. As a result, the patient pool for chronic diseases is expected to drive the number of surgeries performed, which will aid in the growth of disposable laparoscopy devices.​ For instance, according to data published by World Health Organization, 2021, cardiovascular diseases account for 17.9 million deaths globally, followed by cancers (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million).

Thus, due to the benefits associated with minimally-invasive surgeries, the adoption rate has been increasing, which may further increase the market's overall growth over the forecast period.

Laparoscopy Devices Market Trends

Bariatric Surgery Expected to Hold Significant Market Share in the Application Segment

Bariatric surgery or weight loss surgery is one of the major treatment procedures for treating obesity. During this procedure, the size of the stomach is reduced by either removing some parts of the stomach or using a gastric band. Increasing obesity rates among children and adolescents are being witnessed across the globe, leading to several young patients undergoing bariatric surgery.​

The increasing bariatric surgical procedures are likely to raise the demand for disposable laparoscopic devices. For instance, according to a research study by Ergie P.Inocian et al., published in Surgery for Obesity and Related Diseases Journal June 2021, there has been an increasing volume of bariatric surgeries in the Middle East to address obesity and metabolic disorders. Thus, bariatric surgical procedures continue to gain acceptance as a treatment for severe obesity in the Middle-East and North Africa regions, which is expected to impact market growth positively.​

According to the World Health Organization (WHO), in 2021, across the world, obesity has almost increased three-fold since 1975. In the five-19 age bracket, obesity increased from less than 1% to 7% over the same period. The WHO states that most of the world's population live in countries where being overweight and obese kills more people than being underweight. Bariatric surgical procedures cause weight loss by restricting the amount of food the stomach can hold, causing malabsorption of nutrients, or combining both gastric restriction and malabsorption. Laparoscopic bariatric surgery is safe in the elderly population, similar to bariatric procedures.

North America Dominates the Market and Expected to Continue Dominance in the Forecast Period

North America is anticipated to dominate the laparoscopy devices market globally. The factors attributed to the region's high growth are the increasing cases of obesity, various chronic diseases, and the growing adoption of minimally-invasive surgeries.

According to an article published by the Center for Disease Control and Prevention, updated in April 2021, six in ten adults in the US have at least one chronic disease, and four in ten adults have two or more chronic diseases. Thus, the high prevalence of chronic diseases in the country increases the demand for minimally invasive surgeries, thus, driving the laparoscopy devices market.

In addition, organic and inorganic strategies such as mergers and acquisitions and partnerships with key market players are being adopted to strengthen companies' product portfolios and drive the market studied. Also, several product launches in the market are expected to result in lucrative market growth. For instance, in June 2021, Ethicon, part of the Johnson & Johnson Medical Devices Companies, launched ENSEAL X1 Curved Jaw Tissue Sealer, a new advanced bipolar energy device that increases procedural efficiency and provides stronger sealing and better access to more tissue. The device is indicated for colorectal, gynecological, bariatric surgery, and thoracic procedures.

The advantages of minimally-invasive surgeries, such as less invasiveness, the quick recovery time of patients, and the low cost of treatment, have augmented the demand for laparoscopy devices in the region. Furthermore, advancements in various surgical devices from established players in the US are likely to drive market growth in North America.

Laparoscopy Devices Market Competitor Analysis

The global laparoscopy devices market is highly competitive and consists of a number of major players. Companies, like B. Braun Melsungen AG, Boston Scientific Corporation, ConMed Corporation, Johnson & Johnson (Ethicon Inc.), Karl Storz GmbH & Co.KG, Medtronic PLC (Covidien), Olympus Corporation, Richard Wolf GmbH, Smith & Nephew PLC, and Stryker Corporation, among others, hold a substantial share in the laparoscopy devices market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Technological Advancements
    • 4.2.2 Growing Prevalence of Chronic Diseases
    • 4.2.3 Growing Demand for Minimally-Invasive Surgery
  • 4.3 Market Restraints
    • 4.3.1 Lack of Expertise in Laparoscopic Surgeries
    • 4.3.2 High Costs Associated with these Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 Product
    • 5.1.1 Energy Devices
    • 5.1.2 Laparoscopes
    • 5.1.3 Insufflation Devices
    • 5.1.4 Handheld Instruments
    • 5.1.5 Suction/Irrigation Devices
    • 5.1.6 Other Products
  • 5.2 Application
    • 5.2.1 Bariatric Surgery
    • 5.2.2 Gynecological Surgery
    • 5.2.3 Colorectal Surgery
    • 5.2.4 Other Applications
  • 5.3 End User
    • 5.3.1 Ambulatory Centers
    • 5.3.2 Hospitals and Clinics
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 B. Braun Melsungen AG
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 ConMed Corporation
    • 6.1.4 Johnson & Johnson (Ethicon Inc.)
    • 6.1.5 Karl Storz GmbH & Co. KG
    • 6.1.6 Medtronic PLC (Covidien)
    • 6.1.7 Olympus Corporation
    • 6.1.8 Richard Wolf GmbH
    • 6.1.9 Smith & Nephew PLC
    • 6.1.10 Stryker Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS